CEO’s appointment to HTA Review Reference Committee

15 March 2023 - CEO of Medicines Australia, Elizabeth de Somer, has been appointed as the medicines industry representative on ...

Read more →

Updates from the Health Technology Assessment Policy and Methods Review Reference Committee (March 2023)

9 March 2023 - The Health Technology Assessment Policy and Methods Review Reference Committee met on 13 February 2023.  ...

Read more →

PHARMAC releases final response to review

3 March 2023 - "There are 30 actions we committed to in the interim response – these are part of ...

Read more →

“Killing time” one year on, still no final response from PHARMAC to the independent review

28 February 2023 - Today marks one year since the PHARMAC Review was delivered to then Health Minister Andrew Little. ...

Read more →

ABPI response to Lord O'Shaughnessy review

20 February 2023 - The Office for Life Sciences has today announced that Lord James O’Shaughnessy will conduct a review ...

Read more →

Updates from the Health Technology Assessment Policy and Methods Review Reference Committee (February 2023)

10 February 2023 - The Health Technology Assessment Policy and Methods Review Reference Committee met on 27 January 2023.  ...

Read more →

Release of the Strengthening Medicare Taskforce Report

3 February 2023 - The Strengthening Medicare Taskforce Report is now available.  ...

Read more →

Strengthening Medicare for the future

3 February 2023 - The Albanese Government has released the Strengthening Medicare Taskforce report. ...

Read more →

‘Enough sickness’ to share GP load among pharmacists, nurses

2 February 2023 - Pharmacy Guild of Australia president Trent Twomey says there is enough “demand and sickness” to allow ...

Read more →

FDA may not always require post-approval trials to be enrolled before accelerated approvals

30 January 2023 - A FDa official on Monday gave more clues for how the agency plans to wield new authority ...

Read more →

Options for a reformed Prostheses List pre-listing assessment framework and governance structure

31 January 2023 - This report provides a framework and proposes options for governance that would align the Prostheses List processes ...

Read more →

Draft methods (version 7.0): IQWiG is extending the comment period

26 January 2023 - The new deadline is 28 February 2023. ...

Read more →

The 4 biggest questions about the FDA’s forthcoming changes to accelerated approvals

25 January 2023 - Congress just boosted the FDA’s authority over the post-market clinical trials that are a condition of ...

Read more →

Reform Medicare to sustain system

25 January 2023 - Australia’s hybrid public/private healthcare system, including the principle of universal coverage through Medicare, has served the nation ...

Read more →

Consultation on the revised PBS post-market review framework – publication of responses

20 January 2023 - Consultation on a revised draft of the PBS post-market review framework was open from 20 October ...

Read more →